Latest Breaking News On - இதயம் தோல்வி சமூகம் ஆஃப் அமெரிக்கா - Page 2 : comparemela.com
Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.
Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HF Med Cornucopia Center Stage in Upcoming ESC Guideline: Preview
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Kenneth Bescak, MD, F A C C , is recognized by Continental Who s Who
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced the appointment of seasoned medical device executive Chad Hoskins as Chief Executive Officr (CEO). Mr. Hoskins will lead the company as it transitions from early development towards regulatory clearance and commercialization of its novel heart failure treatment, splanchnic ablation for volume management (SAVM), using the Satera™ Ablation System. Axon is poised to disrupt the heart failure market by treating a root cause of the disease rather than simply addressing patient symptoms. We are very pleased with our initial data demonstrating the potential of SAVM to improve the quality of life of heart failure patients with preserved ejection fraction, commented Howard Levin, MD, Co-founder of Axon Therapies and Deerfield Catalyst, a medtech innovation hub. Chad s deep understanding of the heart failure market and proven leade